Related Experiment Video
Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Long-term outcomes of pneumococcal meningitis in childhood and adolescence
Deborah Christie1, Russell M Viner, Kyle Knox
1General and Adolescent Paediatrics Unit, UCL Institute of Child Health, London, UK. Deborah.Christie@uclh.nhs.uk
Insights
Pneumococcal meningitis (PM) significantly impacts children's cognitive, educational, and psychological development, leading to long-term sequelae. These findings support the routine use of the pneumococcal conjugate vaccine for children.
Area of Science:
- Neurology
- Pediatrics
- Public Health
Background:
- Pneumococcal meningitis (PM) can cause long-term adverse outcomes in children.
- Contemporary data on these sequelae are limited, hindering cost-effectiveness analyses for new vaccines.
- A vaccine to prevent PM has been introduced, necessitating evidence for its routine use.
Purpose of the Study:
- To examine the cognitive, educational, psychological, and social outcomes of childhood pneumococcal meningitis.
- To provide data for cost-effectiveness analyses and inform policy on routine childhood vaccination.
Main Methods:
- A population-based case-control study was conducted in two UK regions.
- Children diagnosed with PM (cases) were compared with siblings or neighbours (controls).
- Assessments included IQ, educational attainment, quality of life, and psychological well-being via questionnaires and neuropsychological testing.
Main Results:
- 14% of PM patients experienced hearing impairment compared to 1% of controls.
- Patients showed significantly lower IQ, educational attainment, quality of life, and psychosocial functioning.
- Parent-reported outcomes indicated greater functional disability and psychological difficulties in patients.
Conclusions:
- Pneumococcal meningitis is associated with significant and lasting adverse outcomes in children.
- These sequelae underscore the importance of preventative measures.
- Findings strongly support the international introduction of the pneumococcal conjugate vaccine into routine childhood immunization schedules.
Abstract:
A vaccine to prevent pneumococcal meningitis (PM) has recently been introduced. However, contemporary data to inform cost-effectiveness analysis and justify its routine use are sparse. We examined the cognitive, educational, psychological and social outcomes of PM in childhood. We completed a population-based case-control study in two regions of the UK. Children and young people currently between 3 and 20 years of age that had been diagnosed with PM ≤14 years of age were identified from active regional surveillance. Controls were siblings or neighbours of similar age. Standardised questionnaires and neuropsychological testing was administered to assess IQ, educational attainments, memory, psychological distress, quality of life and hearing impairment. Data were available on 97 patients and 93 controls. Eighty-four patients had a sibling/neighbour-matched control. Both matched and unmatched analyses were completed, and results of the 84 matched comparisons were highly similar to the unmatched. For the total sample, controls were similar in age, ethnicity and socioeconomic status. Median age at meningitis was 11 months. Median time between meningitis and assessment was 6.0 years. In the matched analysis, partial or profound hearing impairment was reported in 14% of patients and 1% of controls. Patients had significantly lower mean full-scale IQ (p = 0.05), verbal IQ (p = 0.0008), numeracy (p = 0.02), total quality of life (p = 0.04), school functioning (p = 0.005), psychosocial functioning (p = 0.001) and psychological difficulties (p = 0.01). Parents of patients reported greater functional disability (p = 0.008), impairment in all aspects of quality of life (p = 0.001) and psychological difficulties (p < 0.0006). Findings for IQ were not materially different when analyses were repeated only in those without hearing impairment. In multivariate regression analysis that included both case-control status and hearing status, both being a patient (p = 0.001) and having profound hearing impairment (p = 0.001) were independently associated with lower full-scale IQ. Conclusions Pneumococcal meningitis is associated with major sequelae. Our findings strongly support the introduction of pneumococcal conjugate vaccine as part of routine childhood vaccination programmes internationally.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
07:01A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction